APA (7th ed.) Citation

XH, W., XW, M., H, X., B, Q., MZ, H., J, C., . . . ZW, L. (2011). STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma. Hepato-gastroenterology, 58(106), 487.

Chicago Style (17th ed.) Citation

XH, Wang, Meng XW, Xing H, Qu B, Han MZ, Chen J, Fan YJ, Lu CQ, and Lu ZW. "STAT3 and Beta-catenin Signaling Pathway May Affect GSK-3beta Expression in Hepatocellular Carcinoma." Hepato-gastroenterology 58, no. 106 (2011): 487.

MLA (9th ed.) Citation

XH, Wang, et al. "STAT3 and Beta-catenin Signaling Pathway May Affect GSK-3beta Expression in Hepatocellular Carcinoma." Hepato-gastroenterology, vol. 58, no. 106, 2011, p. 487.